Stock CELATOR PHARMACEUTICALS INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

News Celator Pharmaceuticals Inc

Equities

US15089R1023

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for Celator Pharmaceuticals Inc
2016 Celator Pharmaceuticals : Jazz Pharma to buy Celator in $1.5 billion deal RE
2016 Celator Pharmaceuticals : Jazz Pharma nears deal to buy Celator for about $1.5 billion - WSJ RE

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Brower Piven Commences An Investigation Into The Proposed Sale Of Celator Pharmaceuticals, Inc. And Encourages Shareholders To Contact The Firm For Additional Information
BU
CELATOR PHARMACEUTICALS, INC. Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Sale to Jazz Pharmaceuticals plc
BU
Celator Pharmaceuticals : Jazz Pharma to buy Celator in $1.5 billion deal
RE
Celator Pharmaceuticals : Jazz Pharma nears deal to buy Celator for about $1.5 billion - WSJ
RE
Steve Cohen’s Point72 says it has perfect U.S. compliance
RE
Celator Pharmaceuticals : CEO Scott Jackson and President Lawrence Mayer Interviewed by The Life Sciences Report
MW
Celator(R) Pharmaceuticals Announces Completion of Its Public Offering and the Exercise in Full of Option to Purchase Additional Units of Common Stock and Warrants to Purchase Common Stock
GL
Celator(R) Pharmaceuticals to be Added to Russell MicroCap Index
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. Stock
  4. News Celator Pharmaceuticals Inc